(Q47749838)

5 February 2018

title

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test. (English)

1 reference

5 February 2018

main subject

lymphocyte

0 references

Stevens–Johnson syndrome

1 reference

6

1 reference

5 February 2018

Grzegorz Porebski

object named as

G Porebski

1

0 references

author name string

T Pecaric-Petkovic

2

1 reference

5 February 2018

M Groux-Keller

3

1 reference

5 February 2018

M Bosak

4

1 reference

5 February 2018

T T Kawabata

5

1 reference

5 February 2018

publication date

1 September 2013

1 reference

5 February 2018

Clinical & Experimental Allergy

published in

1 reference

5 February 2018

volume

43

1 reference

5 February 2018

issue

9

1 reference

5 February 2018

page(s)

1027-1037

1 reference

5 February 2018

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

cites work

1 reference

Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis

21 January 2018

1 reference

Prognostic value of histologic features of toxic epidermal necrolysis.

21 January 2018

1 reference

Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.

21 January 2018

1 reference

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

21 January 2018

1 reference

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

21 January 2018

1 reference

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

The lymphocyte transformation test in the diagnosis of drug hypersensitivity

21 January 2018

1 reference

Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis

21 January 2018

1 reference

Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions

21 January 2018

1 reference

Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR.

21 January 2018

1 reference

In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases.

21 January 2018

1 reference

Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity.

21 January 2018

1 reference

PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection

21 January 2018

1 reference

FOXO3 regulates the CD8 T cell response to a chronic viral infection

21 January 2018

1 reference

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

21 January 2018

1 reference

IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response

21 January 2018

1 reference

The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy

21 January 2018

1 reference

In vitro diagnosis of T cell-mediated drug allergy.

21 January 2018

1 reference

Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization

21 January 2018

1 reference

Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEA.12145

1 reference

5 February 2018

PubMed ID

23957338

1 reference

5 February 2018